These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2485056

  • 21. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study.
    Rappelli A.
    J Hum Hypertens; 1991 Dec; 5 Suppl 2():55-7; discussion 57-8. PubMed ID: 1665178
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide.
    Jones DW, Sands CD.
    Pharmacotherapy; 1991 Dec; 11(2):127-30. PubMed ID: 2052467
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
    Chrysant SG, Neutel JM, Ferdinand KC, INCLUSIVE investigators.
    J Natl Med Assoc; 2009 Apr; 101(4):300-7. PubMed ID: 19397219
    [Abstract] [Full Text] [Related]

  • 28. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G, Delonca J, Moulin C, Giacomino A, Postel-Vinay N, Asmar R, COmparative Study of Efficacy of Irbesartan/HCTZ with Valsartan/HCTZ Using Home Blood Pressure Monitoring in the TreAtment of Mild-to-Moderate Hypertension (COSIMA) Investigators.
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V, Boccanelli A, Ewald S, Girerd X, Heagerty A, Krzesinski JM, Lins R, Rodicio J, Stefenelli T, Woittiez A, Böhm M.
    Clin Drug Investig; 2007 Nov; 27(8):545-58. PubMed ID: 17638395
    [Abstract] [Full Text] [Related]

  • 31. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
    Grassi G, Seravalle G, Brambilla G, Dell'Oro R, Trevano FQ, Fici F, van Bortel L, Mancia G.
    Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
    [Abstract] [Full Text] [Related]

  • 32. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA, McNeil JJ, McGrath BP.
    Am J Cardiol; 1992 Nov 15; 70(15):1299-305. PubMed ID: 1442581
    [Abstract] [Full Text] [Related]

  • 33. Lisinopril-hydrochlorothiazide combination vs lisinopril for the treatment of hypertension.
    Pathé M.
    J Hum Hypertens; 1991 Dec 15; 5 Suppl 2():53-4. PubMed ID: 1665177
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.
    Prisant LM, Weir MR, Papademetriou V, Weber MA, Adegbile IA, Alemayehu D, Lefkowitz MP, Carr AA.
    Am Heart J; 1995 Aug 15; 130(2):359-66. PubMed ID: 7631621
    [Abstract] [Full Text] [Related]

  • 36. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 15; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD.
    Hypertension; 2009 Jul 15; 54(1):32-9. PubMed ID: 19470877
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.